Multicatheter HDR partial-breast irradiation maintained low recurrence through 15 years
Four-day multicatheter HDR partial-breast irradiation produced 3.8% ipsilateral recurrence at 15 years with exclusively grade 1-2 recorded late toxicity.
Four-day multicatheter HDR partial-breast irradiation produced 3.8% ipsilateral recurrence at 15 years with exclusively grade 1-2 recorded late toxicity.
Video and printed education performed similarly, while half of patients preferred video and self-reported anxiety fell from 30% to 5%.
SABR achieved 92.5% one-year local control in oligometastatic breast cancer, while pooled randomized evidence did not definitively establish a PFS benefit.
Across 5,509 evaluable patients, 34% developed late chest-wall pain, although definitions and reported risk factors varied substantially.
Four quality-improvement measures reduced >3-mm chest-wall errors from 21.2% to 4.7%, but sternal marker placement increased skin reactions.
Across 14 studies, 9 of 11 anxiety studies and 3 of 5 pain studies reported significant improvement with virtual reality.
Across 52 studies, SGRT-assisted DIBH reduced mean heart dose by 1.21 Gy and LAD dose by 7.05 Gy versus free breathing.
Left-sided breast IMRT was linked to more repolarization changes, while right-sided treatment produced predominantly rhythm abnormalities.
Iridium-192 has the strongest long-term breast brachytherapy evidence; cobalt-60 is dosimetrically comparable, while ytterbium-169 remains clinically unvalidated.
Five-fraction RT is well supported for selected whole- and partial-breast treatment, while regional nodal and postmastectomy evidence remains less mature.
Higher sinoatrial node low-dose exposure independently tracked with new ECG abnormalities after postoperative breast IMRT in this exploratory retrospective cohort.
CBCT detected breast edema in 37.1% during 26 Gy in five fractions, usually immediately after the first treatment.
After resection of ipsilateral recurrence, five-year locoregional recurrence-free survival was 84.2%, while grade 3 late toxicity was 3.9%.
With 42.56 Gy in 16 fractions, three-year lymphedema was 6.4%, with no new events through five years.
Restricting deep VMAT apertures reduced heart and ipsilateral lung exposure across three linacs while maintaining comprehensive breast and nodal coverage.